Fortin Sébastien, Moreau Emmanuel, Lacroix Jacques, Teulade Jean-Claude, Patenaude Alexandre, C-Gaudreault René
Unité des Biotechnologies et de Bioingénierie, Centre de recherche, C.H.U.Q., Hôpital Saint-François d'Assise, Université Laval, Que., Canada G1L 3L5.
Bioorg Med Chem Lett. 2007 Apr 1;17(7):2000-4. doi: 10.1016/j.bmcl.2007.01.023. Epub 2007 Jan 19.
A series of novel N-phenyl-N'-(2-chloroethyl)urea derivatives potentially mimicking the structure of combretastatin A-4 were synthesized and tested for their cell growth inhibition and their binding to the colchicine-binding site of beta-tubulin. Compounds 2a, 3a, and 3b were found to inhibit cell growth at the micromolar level on four human tumor cell lines. Flow cytometric analysis indicates that the new compounds act as antimitotics and arrest the cell cycle in G(2)/M phase. Covalent binding of 2a, 3a, and 3b to the colchicine-binding site of beta-tubulin was confirmed also using SDS-PAGE and competition assays.
合成了一系列可能模拟康普瑞他汀A - 4结构的新型N - 苯基 - N' - (2 - 氯乙基)脲衍生物,并测试了它们对细胞生长的抑制作用以及与β - 微管蛋白秋水仙碱结合位点的结合能力。发现化合物2a、3a和3b在微摩尔水平上对四种人类肿瘤细胞系的细胞生长具有抑制作用。流式细胞术分析表明,这些新化合物作为抗有丝分裂剂,使细胞周期停滞在G(2)/M期。还使用SDS - 聚丙烯酰胺凝胶电泳和竞争试验证实了2a、3a和3b与β - 微管蛋白秋水仙碱结合位点的共价结合。